Skip to main content

MESA LABORATORIES INC CO

For the period ended Dec 31, 2023. Filed Feb 5, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Feb 5, 2024

MLAB$136.91+7.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

(dollars in thousands, except per share data)

Common Stock
Number of SharesAmountRetained EarningsAOCI*Total
March 31, 20235,369,466$332,076$74,199$(12,795)$393,480
Exercise of stock options and vesting of restricted stock units20,07452--52
Tax withholding on vesting of restricted stock units(5,260)(712)--(712)
Dividends paid, $0.16 per share--(859)-(859)
Stock-based compensation expense-2,968--2,968
Foreign currency translation---(6,661)(6,661)
Net (loss)--(549)-(549)
June 30, 20235,384,280$334,384$72,791$(19,456)$387,719
Exercise of stock options and vesting of restricted stock units7,464304--304
Tax withholding on vesting of restricted stock units(18)(2)--(2)
Dividends paid, $0.16 per share--(862)-(862)
Stock-based compensation expense-3,183--3,183
Foreign currency translation---(1,353)(1,353)
Net (loss)--(1,230)-(1,230)
September 30, 20235,391,726$337,869$70,699$(20,809)$387,759
Exercise of stock options and vesting of restricted stock units2,4152--2
Tax withholding on vesting of restricted stock units(98)(12)--(12)
Dividends paid, $0.16 per share--(862)-(862)
Stock-based compensation expense-2,993--2,993
Foreign currency translation---10,96510,965
Net income--2,116-2,116
December 31, 20235,394,043$340,852$71,953$(9,844)$402,961
Common Stock
Number of SharesAmountRetained EarningsAOCI*Total
March 31, 20225,265,627$313,460$76,675$3,666$393,801
Exercise of stock options and vesting of restricted stock units31,6901,438--1,438
Tax withholding on vesting of restricted stock units(9)(2)--(2)
Dividends paid, $0.16 per share--(843)-(843)
Stock-based compensation expense-3,432--3,432
Foreign currency translation---(15,957)(15,957)
Net (loss)--(1,438)-(1,438)
June 30, 20225,297,308$318,328$74,394$(12,291)$380,431
Exercise of stock options and vesting of restricted stock units42,0142,778--2,778
Tax withholding on vesting of restricted stock units(3,051)(572)--(572)
Dividends paid, $0.16 per share--(852)-(852)
Stock-based compensation expense-4,371--4,371
Foreign currency translation---(13,226)(13,226)
Net income--1,306-1,306
September 30, 20225,336,271$324,905$74,848$(25,517)$374,236
Exercise of stock options and vesting of restricted stock units7,376307--307
Tax withholding on vesting of restricted stock units(1,757)(335)--(335)
Dividends paid, $0.16 per share--(855)-(855)
Stock-based compensation expense-2,056--2,056
Foreign currency translation---11,34511,345
Net income--451-451
December 31, 20225,341,890$326,933$74,444$(14,172)$387,205

*Accumulated Other Comprehensive (Loss) Income.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.